Octreotide induced remission of a refractory small cell carcinoma of the endometrium.
作者信息
Verschraegen C. F., Matei C., Loyer E., Malpica A., Tornos C., Kudelka A. P., Kavanagh J. J.
机构信息
Section of Gynecology Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA; Department of Radiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA; Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA; Department of Pathology, St. Luke Episcopal Hospital, Houston, Texas, USA.
出版信息
Int J Gynecol Cancer. 1999 Jan;9(1):80-85. doi: 10.1046/j.1525-1438.1999.09886.x.
This is the first report of remission obtained with octreotide in a woman diagnosed with recurrent small cell carcinoma of the endometrium with neuroendocrine features, refractory to a combination of etoposide, cisplatin, and radiation therapy. Stabilization of disease was obtained with a combination of tamoxifen and leuprolide depot. Regression of disease was then achieved by the addition of octreotide. The use of octreotide as an antitumor agent is reviewed.
Zotero 插件